Harry Pitt Building
Reading, England, RG6 6ES, United Kingdom
Location status: Recruiting
NCT Number: NCT07469462
This clinical trial investigates the effects of Vitamin B6 supplementation on neural inhibition using electroencephalography (EEG), in relation to depression and anxiety symptoms in participants from the general population with a relatively high level of symptoms at baseline. Researchers will compare a placebo group to high-dose Vitamin B6 to test the hypothesis that Vitamin B6 moves the excitation/inhibition balance towards inhibition.
Interested in participating?
Request Info18 year–41 year
All sexes
Interventional
Not applicable
Reading, England, RG6 6ES, United Kingdom
Location status: Recruiting
The primary question this trial aims to answer is:
Secondary research questions are:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
100mg PLP in the form of a tablet, taken once a day for 1 week
Placebo supplement in the form of a capsule.
Time frame: From enrolment to the end of treatment 1 week later
Time frame: From enrolment to the end of treatment 1 week later
Time frame: From enrolment to the end of treatment 1 week later
Time frame: From enrolment to the end of treatment 1 week later
Time frame: From enrolment to the end of treatment 1 week later
We will quantify Vitamin B6 in capillary blood samples
Contact information is provided by the study sponsor or research team.
Alex Cameron
CONTACT
David T Field
CONTACT
University of Reading
Other
An EEG Study to Investigate the Effect of High-dose Vitamin B6 Supplementation on Neural Activity in Relation to Depression and Anxiety Symptoms.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07692269
Anxiety, Anxiety Disorders
Beijing, Beijing Municipality, China
View Trial DetailsNCT07717723
Anxiety, Anxiety Disorders
Sacramento, California, United States
View Trial DetailsNCT07722949
Anxiety, Anxiety Disorders
Faisalābad, Punjab Province, Pakistan
View Trial DetailsNCT06820723
Anxiety, Anxiety Disorders
Columbus, Ohio, United States
View Trial Details